Dear Member,
The guidance surrounding the flu vaccination season 2021/22 has now been published. The service will commence on 1st September 2021 and is commissioned until 31st March 2022.
Key information:
1. Click here to download the service specification and PGD
a). All practitioners providing the service must read, understand and sign the relevant documents
2. Click here to read through the PSNC briefing document which contains essential information for the provision of the service
3. Download the PharmaPlus flu SOP (attached)
4. Staff training on vaccinations must be up to date
a). Face-to-face training on injection technique and basic life support must be attended every 3 years
b). Must undertake annual update training – this can be self-directed learning and use of online training materials
c). The CPPE Vaccination Services Declaration of Competence (DoC) must be worked through and completed every 2 years
5. Vaccinations can be offered in any area of the pharmacy where suitable facilities are available and patient confidentiality is able to be respected. However, the vaccination must take place in the
consultation room wherever the patient expresses this preference.
6. Click here to download guidance on providing a COVID safe approach to the service
7. Flu claims must be made via MYS
8. PQS Requirement – You must engage with the PCN, via the Pharmacy PCN Lead, to increase flu vaccination uptake within the PCN’s eligible population.
a). Meet the thresholds for vaccination of the 65 years and over across the PCN (80-86% of eligible patients vaccinated) and
b). Contractors will need to administer 30 or more flu vaccinations to qualify for a payment
9. See table for which vaccines can be used:
|
|
Age Group
|
Vaccine to be used
|
|
Aged 18 to 64 (inc at risk, pregnant women, and the 50 to 64 year old cohorts)
|
Offer:
- QIVc (Flucelvax Tetra - Seqirus) or
- QIVr (Supemtek - Sanofi)
Or QIVe if the above are not available
|
|
Aged 65 years and over
|
Offer:
Or QIVc (Flucelvax) or QIVr (Supemtek) if the above are not available
It is recommended aQIV is offered ‘off-label’ to 64 year olds turning 65 years before 31st March 2022.
|
|
What is the national protocol?
• This has not currently been published but maybe published to aid the provision of the flu vaccination service
• Allows those who are registered healthcare professionals who cannot operate under a PGD, and those who are not registered healthcare professionals, in the context of the flu vaccination service, to administer a licensed influenza vaccine. Any national protocol for vaccines will be developed by PHE and will be written similarly to a PGD.
• Provides flexibility to define the training and competence requirements of vaccinators.
• It also allows the process of administration to be split into its component parts, i.e. clinical assessment and consent, preparation of the vaccine (not required for flu vaccine) and administration of the vaccine.
• All these stages can be done by one competent person (the registered healthcare professional), but these tasks can also be split with each person trained and authorised to complete their specific task as defined in the protocol.
• The clinical assessment and consent process must be undertaken by a registered healthcare professional as defined within the protocol.
• A clinical supervisor, who must be a pharmacist, must be present and take overall responsibility for provision of vaccination under the protocol at all times and be identifiable to service users
• For further information please click here to see the PSNC briefing.
As always, please contact the PharmaPlus team for any further support.
Regards,
|
|
|
